首页> 美国卫生研究院文献>other >Computational Evaluation of HIV-1 gp120 Conformations of Soluble Trimeric gp140 Structures as Targets for de Novo Docking of First- and Second-Generation Small-Molecule CD4 Mimics
【2h】

Computational Evaluation of HIV-1 gp120 Conformations of Soluble Trimeric gp140 Structures as Targets for de Novo Docking of First- and Second-Generation Small-Molecule CD4 Mimics

机译:可溶性三聚体gp140结构的HIV-1 gp120构象作为第一代和第二代小分子CD4模拟物从头对接的目标的计算评估。

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Small-molecule CD4 mimics (SMCM’s) bind to the gp120 subunit of the HIV-1 envelope glycoprotein (Env) and have been optimized to block cell infection in vitro. The lack of the V1/2 and V3 loops and the presence of the β2/3 and β20/21 strands (bridging sheet) in the available structures of the monomeric gp120 core may limit its applicability as a target for further synthetic optimization of SMCM potency and/or breadth. Here, we employ a combination of binding-site search, docking, estimation of protein–ligand interaction energy, all-atom molecular dynamics, and ELISA-based CD4-binding competition assays to create, characterize, and rationalize models of first- and second-generation of SMCM’s bound to the distinct, trimeric BG505 SOSIP.664 structures 4NCO and 4TVP containing V1/2 and V3 loops with no bridging sheet. We demonstrate that the in silico neutralization of the highly conserved D368 is necessary to obtain the correct orientation of SMCM in their binding site when docking against the monomeric gp120 core. The computational results correlate with IC50’s measured in CD4 binding competition ELISA and with KD’s measured on gp120 core monomer. This supports the hypothesis that the 4NCO trimeric structure represents a viable target for further SMCM’s optimization with advantages over both the 4TVP trimer and gp120 core monomer. Finally, the docking protocol has been optimized to screen compounds that can clearly interact with the highly conserved residue D368, increasing the likelihood of future optimizations to arrive at SMCM’s with a broader spectrum of activity.
机译:小分子CD4模仿物(SMCM)与HIV-1包膜糖蛋白(Env)的gp120亚基结合,并经过优化以阻断体外细胞感染。 gp120单体核的可用结构中缺少V1 / 2和V3环以及β2/ 3和β20/ 21链(桥接片)可能会限制其作为SMCM效能进一步合成优化的目标的适用性和/或广度。在这里,我们结合结合位点搜索,对接,蛋白质-配体相互作用能的估计,所有原子的分子动力学以及基于ELISA的CD4结合竞争测定法,以创建,表征和合理化第一和第二个模型代的SMCM绑定到独特的三聚体BG505 SOSIP.664结构4NCO和4TVP,其中包含V1 / 2和V3环而没有桥接片。我们证明,当与单体gp120核心对接时,高度保守的D368的计算机中和是获得SMCM在其结合位点的正确方向所必需的。计算结果与在CD4结合竞争ELISA中测得的IC50和在gp120核心单体上测得的KD相关。这支持以下假设:4NCO三聚体结构是进一步SMCM优化的可行目标,并且具有优于4TVP三聚体和gp120核心单体的优势。最后,对接方案已经过优化,可以筛选出可以与高度保守的残基D368清楚相互作用的化合物,从而增加了将来进行优化以达到具有更广泛活性的SMCM的可能性。

著录项

相似文献

  • 外文文献
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号